GO is the most frequent extrathyroidal manifestation of Graves' disease, although it may
rarely occur in euthyroid/hypothyroid patients with chronic autoimmune thyroiditis. It is a …

Methods: We reviewed cases of TED investigated with CT and Magnetic Resonance
Imaging (MRI) in our department. We assessed the findings of imaging studies and their role …

Background: Thyroid eye disease (TED) is an autoimmune disorder of the orbit and the most
frequent extrathyroidal manifestation of Graves' disease but it may rarely occur in …

In Graves' ophthalmopathy (GO) it is important to distinguish acute inflammation at an early
stage, responsive to immunosuppressive treatment, from inactive fibrotic end stage disease …

Purpose: To describe the clinical features of thyroid eye disease (TED) in patients
presenting at a tertiary eye care centre in North India and to identify factors predictive of …

The use of selenium, in mild TED, seems to limit disease progression without carrying the
risk of relevant side-effects. Biological agents may provide an effective and long lasting …

Recent new insights into the molecular basis of thyroid eye disease have led to the use of
more specific therapies such as monoclonal antibodies This review explores the traditional …

Graves' Orbitopathy (GO) is an autoimmune orbital disorder usually presenting as a sequala
of autoimmune thyroid disease. The presence of GO is associated with increased …

AIM To describe a series of Italian patients with orbital metastasis focusing on the outcomes
in relation to the different primary site of malignancy. METHODS Retrospective chart review …

Background Assessment of the activity of Graves' ophthalmopathy (GO) is difficult. Existing
methods need improvement. Purpose Investigate the application of multiparametric …